Invention Grant
- Patent Title: Composition comprising GLP-1 receptor agonist and glucagon receptor agonist and application thereof
-
Application No.: US16066586Application Date: 2016-12-28
-
Publication No.: US10894076B2Publication Date: 2021-01-19
- Inventor: Michael Min Xu , Wei Lv , Yinghui Zhang , Xiaosu Luo
- Applicant: PEGBIO CO., LTD.
- Applicant Address: CN Jiangsu
- Assignee: PEGBIO CO., LTD.
- Current Assignee: PEGBIO CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: Workman Nydegger
- Priority: CN201511017796 20151229
- International Application: PCT/CN2016/112674 WO 20161228
- International Announcement: WO2017/114425 WO 20170706
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61K38/17 ; A61K45/06 ; A61K47/60 ; A61P3/04 ; A61P3/06 ; A61P3/10
Abstract:
The present invention provides a composition comprising a GLP-1 receptor agonist and a glucagon receptor agonist and an application of the composition. More specifically, the present invention provides a pharmaceutical composition comprising a pharmaceutically effective amount of the GLP-1 receptor agonist and the glucagon receptor agonist, wherein the GLP-1 receptor agonist and the glucagon receptor agonist independently form a conjugate with a hydrophilic polymer, or the GLP-1 receptor agonist and the glucagon receptor agonist jointly form a conjugate with the hydrophilic polymer.
Public/Granted literature
- US20190134161A1 COMPOSITION COMPRISING GLP-1 RECEPTOR AGONIST AND GLUCAGON RECEPTOR AGONIST AND APPLICATION THEREOF Public/Granted day:2019-05-09
Information query
IPC分类:
